“…Examples of such programs include hearing-targeted cCMV testing, in which all infants who fail their newborn hearing screening are then tested for cCMV, and universal/routine screening programs, in which all infants are screened for cCMV regardless of apparent risk factors [ 40 , 44 , 45 ]. Such programs have been found to be effective and acceptable in several studies [ 46 , 47 , 48 , 49 , 50 ], although the debate about cost-effectiveness persists [ 51 ]. As a more nuanced understanding is being gained about the possible long-term outcomes of cCMV [ 43 , 50 , 52 ], as well as the effectiveness of early interventions [ 53 , 54 , 55 ], the risk–benefit analysis may be more clearly weighted towards systematic screening.…”